Zaid Ali A Alhelal

Zaid Alhelal practices at Renaissance Manor On Cabot in Agawam, Massachusetts.

Zaid Alhelal's NPI, 1750875084, was assigned on June 20, 2018. Zaid Alhelal holds Massachusetts license 1015392.

Zaid Alhelal's primary practice is Renaissance Manor on Cabot, at 1 S End Bridge Cir, Agawam, MA 01001 in Hampden County. The practice phone is (413) 536-3435.

Zaid Alhelal's primary practice is Renaissance Manor On Cabot in Agawam, Massachusetts. Zaid Alhelal is also affiliated with Baystate Medical Center. The medical group on file is Baystate Medical Practices. Dmand AI also links Zaid Alhelal to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zaid Alhelal practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Zaid Alhelal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Zaid Alhelal is licensed in Massachusetts.

CMS data shows 374 Medicare services from Zaid Alhelal across 3 procedure codes in 2024, for 381 Medicare patients. Medicare paid $44,003 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 381 Medicare patients who saw Zaid Alhelal in 2024. The largest group is 75 to 84, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zaid Alhelal's median patient age at 73, with 46% women.

In 2020, Zaid Alhelal wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $44 in total drug cost. In 2019, CMS named 42 claims across 2 drugs.

Zaid Alhelal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Zaid Alhelal from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $61.